Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2017   |   Volume: 6   |   Issue: 1   |   Page: 56-61     View issue

Clinical profile and outcomes of granulocytic sarcoma among myeloid malignancies treated in a tertiary care center


, ,
Abstract

Introduction: Granulocytic sarcoma (GS) is a rare tumorous collection of immature myeloid cells in extramedullary sites. Patients and Methods: We reviewed all treated patients of myeloid malignancies presenting to a tertiary referral Centre for treatment of Malignant disorders in western part of India. Using the database for patients diagnosed between Jan 2010 and Dec 2015, a study was conducted to detect the incidence, clinical features, and outcomes in patient presenting with GS. Results: Our study had 400 patients with myeloid malignancies out of which GS was diagnosed in 07 patients which constituted 1.7% of patients of all myeloid neoplasms. All received standard protocol based treatment. Five patients were in complete remission and one had partial remission after treatment.

Cite this article
Vancouver
Singh R, Viswanath S, Maleskar D. Clinical profile and outcomes of granulocytic sarcoma among myeloid malignancies treated in a tertiary care center. Clin Cancer Investig J. 2017;6(1):56-61. https://doi.org/10.4103/ccij.ccij_164_16
APA
Singh, R., Viswanath, S., & Maleskar, D. (2017). Clinical profile and outcomes of granulocytic sarcoma among myeloid malignancies treated in a tertiary care center. Clinical Cancer Investigation Journal, 6(1), 56-61. https://doi.org/10.4103/ccij.ccij_164_16

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513